The rebranding is a cosmetic corporate event with no direct trading catalyst. Monitor for any subsequent filings that may accompany the strategic narrative shift (e.g., earnings, partnerships, or capital markets activity). The ticker change may cause minor technical adjustments but should not materially affect valuation.
Price Chart
Executive Summary
Oncology Institute, Inc. is rebranding as Starling Oncology, Inc. effective July 28, 2026, with its Nasdaq ticker changing from TOI to STLN starting August 4, 2026. The name change and symbol change are purely administrative, with no impact on stockholder rights, CUSIP number, or business operations. No financial data, guidance, or material operational changes were disclosed.
Key Facts
- Company name changed from The Oncology Institute, Inc. to Starling Oncology, Inc. on July 28, 2026
- Ticker symbol changes from TOI to STLN, effective August 4, 2026 on Nasdaq
- No stockholder approval required; no change in stockholder rights or CUSIP number (remains 68236X100)
- Press release contains forward-looking statements about reaching profitability and scaling, but provides no concrete financial figures or guidance
Financial Impact
No financial figures reported in the filing; no impact on revenue, earnings, capital structure, or stockholder rights
Risk Factors
- No disclosure of underlying financial performance — market may interpret rebranding as a signal of strategic shift without supporting data
- Ticker symbol changes can cause temporary confusion or liquidity disconnects in the first few days post-effective
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 6 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001079973-26-000997 |
| Exhibit: ex99x1.htm | 0001079973-26-000997 |
| Exhibit: ex3x1.htm | 0001079973-26-000997 |
| Document: 0001079973-26-000997-index-headers.html | 0001079973-26-000997 |
| Document: 0001079973-26-000997-index.html | 0001079973-26-000997 |
| Document: 0001079973-26-000997.txt | 0001079973-26-000997 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 3, 2026 12w ago | 8-K | $5.13 | awaiting T+20 | — | — |
Jul 22, 2026 13w ago | Insider Buy | $5.29 | awaiting T+20 | — | — |
Jul 22, 2026 13w ago | Insider Cluster | $5.29 | awaiting T+20 | — | — |
Jul 16, 2026 14w ago | Insider Cluster | $5.35 | awaiting T+20 | — | — |
Jul 13, 2026 15w ago | Insider Buy | $6.25 | awaiting T+20 | — | — |
Jul 7, 2026 15w ago | 8-K | $5.65 $5.13 | ▼ −9.20% | ▼ −12.48% | — |
Jun 11, 2026 19w ago | Institutional Cluster | $5.13 $5.85 | ▲ +14.04% | ▲ +12.14% | — |
Jun 9, 2026 19w ago | Insider Cluster | $4.68 $5.85 | ▲ +25.00% | ▲ +21.38% | — |
Apr 27, 2026 26w ago | Press Release | $3.33 $4.59 | ▲ +37.84% | ▲ +32.88% | — |
Apr 9, 2026 28w ago | Insider Cluster | $3.11 $3.80 | ▲ +22.19% | ▲ +14.62% | — |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers